• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张钊瑞,胡延臣.化学药品口崩片药学研究关注点探讨[J].药学研究,2025,44(4):359-363[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2506次   下载 885次 本文二维码信息
码上扫一扫!
化学药品口崩片药学研究关注点探讨
张钊瑞,胡延臣
字体:加大+|默认|缩小-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
口崩片系指在口腔内不需要用水即能迅速崩解或溶解的片剂。口崩片作为片剂剂型之一,具有服用方便、在口腔内迅速崩解或溶解等优势,有助于改善患者用药依从性。本文结合口崩片相关指导原则、药典标准及上市药品情况,对口崩片处方工艺、质量研究和质量控制、稳定性和包装等方面进行探讨。希望有助于口崩片的开发,期待更多高质量口崩片上市,满足特定患者的用药需求。
关键词:  口崩片  处方工艺  质量控制  稳定性和包装  新药注册
DOI:10.13506/j.cnki.jpr.2025.04.009
基金项目:
出版日期:2025-04-25
Discussion on pharmaceutical research concerns of chemical orally disintegrating tablets
ZHANG Zhaorui,HU Yanchen
(Center for Drug Evaluation, National Medical Products Administration,Beijing 100076,China)
Abstract:
Orally disintegrating tablets are tablets that can disintegrate or dissolve quickly without water in the mouth. As one of the dosage forms of tablets, orally disintegrating tablets have the advantages of easy to take, rapid disintegration or dissolution in the mouth, which is helpful to improve the patients compliance. Discussions on formulation and manufacturing process, quality research and quality control, stability and packaging of orally disintegrating tablets were based on the marketing drug, pharmacopoeia standards and guiding principles at home and abroad. These discussions are expected to guide the development of orally disintegrating tablets, and promote marketing of high-quality orally disintegrating tablets to meet the needs of specific patients.
Key words:  Orally disintegrating tablets  Formulation and manufacturing process  Quality control  Stability and packaging
今日访问量:2644    总访问量:55339159
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司